BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33283580)

  • 41. Successful pregnancies in patients with BCR-ABL-positive leukemias treated with interferon-alpha therapy during the tyrosine kinase inhibitors era.
    Balsat M; Etienne M; Elhamri M; Hayette S; Salles G; Thomas X
    Eur J Haematol; 2018 Dec; 101(6):774-780. PubMed ID: 30179268
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patients' and hematologists' concerns regarding tyrosine kinase-inhibitor therapy in chronic myeloid leukemia.
    Jiang Q; Yu L; Gale RP
    J Cancer Res Clin Oncol; 2018 Apr; 144(4):735-741. PubMed ID: 29380058
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience.
    Chamoun K; Kantarjian H; Atallah R; Gonzalez GN; Issa GC; Rios MB; Garcia-Manero G; Borthakur G; Ravandi F; Jain N; Daver N; Konopleva M; DiNardo CD; Kadia T; Pemmaraju N; Jabbour E; Cortes J
    J Hematol Oncol; 2019 Jan; 12(1):1. PubMed ID: 30606227
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does the frequency of molecular monitoring after tyrosine kinase inhibitor discontinuation affect outcomes of patients with chronic myeloid leukemia?
    Kong JH; Winton EF; Heffner LT; Chen Z; Langston AA; Hill B; Arellano M; El-Rassi F; Kim A; Jillella A; Kota VK; Bodó I; Khoury HJ
    Cancer; 2017 Jul; 123(13):2482-2488. PubMed ID: 28241101
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bosutinib for the treatment of chronic myeloid leukemia.
    Doan V; Wang A; Prescott H
    Am J Health Syst Pharm; 2015 Mar; 72(6):439-47. PubMed ID: 25736937
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of chronic myeloid leukemia during pregnancy: a retrospective analysis at a single center.
    Moura AC; Delamain MT; Duarte GBO; Lorand-Metze I; Souza CA; Pagnano KBB
    Hematol Transfus Cell Ther; 2019; 41(2):125-128. PubMed ID: 31079659
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcome of pregnancy in chronic myeloid leukaemia patients treated with tyrosine kinase inhibitors: short report from a single centre.
    Alizadeh H; Jaafar H; Rajnics P; Khan MI; Kajtár B
    Leuk Res; 2015 Jan; 39(1):47-51. PubMed ID: 25455655
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Managing pregnancy in chronic myeloid leukaemia.
    Palani R; Milojkovic D; Apperley JF
    Ann Hematol; 2015 Apr; 94 Suppl 2():S167-76. PubMed ID: 25814083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Incidence and outcome of second malignancies in patients with chronic myeloid leukemia during treatment with tyrosine kinase inhibitors.
    Nakazato T; Iriyama N; Tokuhira M; Ishikawa M; Sato E; Takaku T; Sugimoto KJ; Fujita H; Fujioka I; Kimura Y; Aisa Y; Iwanaga E; Asou N; Kizaki M; Hatta Y; Komatsu N; Kawaguchi T
    Med Oncol; 2018 May; 35(7):99. PubMed ID: 29846829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring.
    Jabbour E; Kantarjian H
    Am J Hematol; 2020 Jun; 95(6):691-709. PubMed ID: 32239758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of chronic renal injury in patients with chronic myeloid leukemia in the chronic phase receiving tyrosine kinase inhibitors.
    Ren X; Qin Y; Huang X; Zuo L; Jiang Q
    Ann Hematol; 2019 Jul; 98(7):1627-1640. PubMed ID: 31089794
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A retrospective study of the prescribing and outcomes of tyrosine kinase inhibitors in chronic myeloid leukaemia over a period of more than 10 years.
    Lang AS; Mounier M; Roques M; Chretien ML; Boulin M
    J Clin Pharm Ther; 2015 Aug; 40(4):391-7. PubMed ID: 25865674
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ponatinib: A new tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Shamroe CL; Comeau JM
    Ann Pharmacother; 2013 Nov; 47(11):1540-6. PubMed ID: 24265264
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of pregnant chronic myeloid leukemia patients.
    Abruzzese E; Trawinska MM; de Fabritiis P; Baccarani M
    Expert Rev Hematol; 2016 Aug; 9(8):781-91. PubMed ID: 27352939
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of CML in pregnancy.
    Robertson HF; Apperley JF
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):123-128. PubMed ID: 36485083
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiovascular mortality among chronic myeloid leukemia patients in the pre-tyrosine kinase inhibitor (TKI) and TKI eras: a surveillance, epidemiology and end results (SEER) analysis.
    Wang Q; Jiang C; Zhang Y; Zhang Y; Yue B; Zheng-Lin B; Zhao Y; Mauro MJ
    Leuk Lymphoma; 2020 May; 61(5):1147-1157. PubMed ID: 31985308
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice.
    Fava C; Rege-Cambrin G; Dogliotti I; Cerrano M; Berchialla P; Dragani M; Rosti G; Castagnetti F; Gugliotta G; Martino B; Gambacorti-Passerini C; Abruzzese E; Elena C; Pregno P; Gozzini A; Capodanno I; Bergamaschi M; Crugnola M; Bocchia M; Galimberti S; Rapezzi D; Iurlo A; Cattaneo D; Latagliata R; Breccia M; Cedrone M; Santoro M; Annunziata M; Levato L; Stagno F; Cavazzini F; Sgherza N; Giai V; Luciano L; Russo S; Musto P; Caocci G; Sorà F; Iuliano F; Lunghi F; Specchia G; Pane F; Ferrero D; Baccarani M; Saglio G
    Haematologica; 2019 Aug; 104(8):1589-1596. PubMed ID: 30819917
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use patterns of first-line inhibitors of tyrosine kinase and time to change to second-line therapy in chronic myeloid leukemia.
    Machado-Alba JE; Machado-Duque ME
    Int J Clin Pharm; 2017 Aug; 39(4):851-859. PubMed ID: 28508322
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NCCN Guidelines Updates: Discontinuing TKI Therapy in the Treatment of Chronic Myeloid Leukemia.
    Shah NP
    J Natl Compr Canc Netw; 2019 May; 17(5.5):611-613. PubMed ID: 31117031
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Characteristics and clinical outcome of T315I mutation in Philadelphia chromosome-positive acute lymphoblastic leukemia and chronic myeloid leukemia].
    Wang J; Zhang Y; Zu Y; Li Z; Li M; Song Y
    Zhonghua Xue Ye Xue Za Zhi; 2016 Feb; 37(2):110-4. PubMed ID: 27014979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.